|Articles|May 1, 2013
- Pharmaceutical Executive-05-01-2013
- Volume 0
- Issue 0
PE, May 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Is That VBP on the Horizon, or a Mirage?about 13 years ago
Country Report: Austriaabout 13 years ago
The Friendly Persuasion — An Interview with Fred Hassanabout 13 years ago
Whistling Past the Graveyardabout 13 years ago
The Patent Black Labelabout 13 years ago
It's Time For a Code of Ethics in Patient Educationabout 13 years ago
The Health Information Advantageabout 13 years ago
Generic Drug Gains and GrumblesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Evolving Relationship Between FDA and Biotech
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Implications of GLP-1s Replacing Oncology as the Key Value Driver
4
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
5